Marker Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
4.00
|
|
Average Rating
|
5.00
|
|
# Strong Buys
|
1
|
|
# Buys
|
0
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.12
|
-0.08
|
0.04
|
33.33%
|
|
2022-06-30
|
-0.13
|
-0.11
|
0.02
|
15.38%
|
|
2022-03-31
|
-0.13
|
-0.12
|
0.01
|
7.69%
|
|
2021-12-31
|
-0.13
|
-0.12
|
0.01
|
7.69%
|
|
2021-09-30
|
-0.13
|
-0.15
|
-0.02
|
-15.38%
|
|
2021-06-30
|
-0.12
|
-0.13
|
-0.01
|
-8.33%
|
|
2021-03-31
|
-0.14
|
-0.16
|
-0.02
|
-14.29%
|
|
2020-12-31
|
-0.16
|
-0.18
|
-0.02
|
-12.50%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.31
|
|
2021-12-31
|
-0.56
|
|
2020-12-31
|
-0.62
|
|
2019-12-31
|
-0.47
|
|
2018-12-31
|
-2.05
|
|
2017-12-31
|
-1.20
|
|
2016-12-31
|
-0.93
|
|
2015-12-31
|
-9.57
|
|
2014-12-31
|
-52.36
|
|
2013-12-31
|
-70.04
|
|
2012-12-31
|
-111.40
|
|
2011-12-31
|
-56.15
|
|
2010-12-31
|
-154.45
|
|
2009-12-31
|
-374.06
|
|
2008-12-31
|
-1108.20
|
|
2007-12-31
|
-2432.92
|
|
2006-12-31
|
-1649.08
|
|
2005-12-31
|
-1024.06
|
|
2004-12-31
|
-3908.56
|
|
2003-12-31
|
-193747.81
|